In the present work, we used antitumour effector CD8+ T cells from OT-I mice to assess the possibility of magnetically target and accumulate tumour-specific CD8+ T cells in solid tumours as well as in the tumour-draining LN for cancer treatment and potentially reduce metastasis spreading. This evidence concerns the gene CD8A and neoplasm.